Comparative Effectiveness of Tirzepatide Versus Dulaglutide or Semaglutide on Major Cardiovascular Events in Type 2 Diabetes and Cardiovascular Disease: Insights From Two Target-Trial Emulations.

Journal:

Diabetes Care

Published:

2026-03-05

DOI:

10.2337/dc25-3063

Affiliations:

5

Authors:

9

Go to article

Institutions	Authors	Share
Brigham and Women's Hospital (BWH), United States of America (USA)	6.666667	0.74
Massachusetts General Hospital (MGH), United States of America (USA)	2.000000	0.22
VA Boston Healthcare System, United States of America (USA)	0.333333	0.04

Interested in Clinical Sciences?